Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Sabine Yerly and Nicolas Vuilleumier.
Sabine Yerly
Connection Strength
1.206
Nicolas Vuilleumier
  1. SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1. Eur J Clin Invest. 2021 Nov; 51(11):e13661.
    View in: PubMed
    Score: 0.240
  2. Head-to-Head Evaluation of Five Automated SARS-CoV-2 Serology Immunoassays in Various Prevalence Settings. J Clin Med. 2021 Apr 10; 10(8).
    View in: PubMed
    Score: 0.235
  3. Head-to-Head Accuracy Comparison of Three Commercial COVID-19 IgM/IgG Serology Rapid Tests. J Clin Med. 2020 Jul 24; 9(8).
    View in: PubMed
    Score: 0.223
  4. Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance. Clin Microbiol Infect. 2021 Nov; 27(11):1695.e7-1695.e12.
    View in: PubMed
    Score: 0.060
  5. Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland. Nat Commun. 2021 06 08; 12(1):3455.
    View in: PubMed
    Score: 0.059
  6. Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study. Clin Microbiol Infect. 2021 Jan 20.
    View in: PubMed
    Score: 0.058
  7. Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT). Emerg Microbes Infect. 2020 Dec; 9(1):2394-2403.
    View in: PubMed
    Score: 0.057
  8. Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma. PLoS One. 2020; 15(9):e0238089.
    View in: PubMed
    Score: 0.056
  9. Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test. Eur J Clin Invest. 2020 Oct; 50(10):e13357.
    View in: PubMed
    Score: 0.056
  10. Validation of a commercially available SARS-CoV-2 serological immunoassay. Clin Microbiol Infect. 2020 Oct; 26(10):1386-1394.
    View in: PubMed
    Score: 0.056
  11. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020 08 01; 396(10247):313-319.
    View in: PubMed
    Score: 0.055
  12. Comparison of analytical performances of the Roche Cobas 6800 CT/NG assay with the Abbott m2000 Real Time CT/NG assay for detecting Chlamydia trachomatis and Neisseria gonorrhoeae. J Med Microbiol. 2019 Feb; 68(2):197-200.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.